S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
BREAKING: Tiny biotech successfully treats blindness (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
BREAKING: Tiny biotech successfully treats blindness (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
BREAKING: Tiny biotech successfully treats blindness (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
BREAKING: Tiny biotech successfully treats blindness (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
BREAKING: Tiny biotech successfully treats blindness (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
BREAKING: Tiny biotech successfully treats blindness (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
BREAKING: Tiny biotech successfully treats blindness (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
BREAKING: Tiny biotech successfully treats blindness (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Fed's Shocking New Plan to Control Your Money (Ad)
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
OTCMKTS:LNXSF

LANXESS Aktiengesellschaft - LNXSF Stock Forecast, Price & News

$40.05
0.00 (0.00%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$40.05
▼
$40.05
50-Day Range
$37.49
▼
$51.76
52-Week Range
$27.78
▼
$52.00
Volume
50 shs
Average Volume
432 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
1.25%
Price Target
$53.29

LANXESS Aktiengesellschaft MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
33.0% Upside
$53.29 Price Target
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.24 out of 5 stars

See Top Rated MarketRank™ Stocks Here

LNXSF stock logo

About LANXESS Aktiengesellschaft (OTCMKTS:LNXSF) Stock

LANXESS AG is a holding company, which engages in the provision of specialty chemicals. It operates through the following segments: Advanced Intermediates, Specialty Additives, Consumer Protection, and Engineering Materials. The Advanced Intermediates segment comprises operational business areas that essentially manufacture standardized and high-volume products in capital-intensive and predominantly continuous production processes. The Specialty Additives consists of operational business units that manufacture additives in chemical production processes. The Consumer Protection segment refers to operational business units that manufacture consumer protection products in chemical production processes. The Engineering Materials operates business units which manufacture high-tech plastics and high-performance composites using mainly continuous production processes. The company was founded on July 1, 2004 and is headquartered in Cologne, Germany.

Receive LNXSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LANXESS Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

LNXSF Stock News Headlines

March 22, 2023 | americanbankingnews.com
LANXESS Aktiengesellschaft (OTCMKTS:LNXSF) Given Consensus Recommendation of "Moderate Buy" by Analysts
March 14, 2022 | msn.com
POINT72 Europe (London) geht 0,58% Short-Position in Lanxess ein
March 25, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
March 12, 2022 | finanznachrichten.de
Lanxess Annual Earnings Fall, But Sales Improve
March 11, 2022 | msn.com
Chemie-Konzern: Ukraine-Krieg und Chempark-Explosion kosten Lanxess viele Millionen
March 11, 2022 | seekingalpha.com
LANXESS Aktiengesellschaft reports FY results
March 11, 2022 | msn.com
FOKUS 1-Lanxess will hohen Kosten trotzen - Deutliches Ergebnisplus erwartet
March 11, 2022 | msn.com
Lanxess warnt vor Importstopp und lobt Habeck
March 25, 2023 | Weiss Ratings (Ad)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
March 11, 2022 | sg.finance.yahoo.com
Chemicals group Lanxess eyes higher 2022 profits despite rising costs
March 11, 2022 | msn.com
Lanxess will hohen Kosten trotzen - Deutliches Ergebnisplus erwartet
March 10, 2022 | msn.com
Psquared kappt Short-Position in Lanxess auf 0,67%
March 9, 2022 | msn.com
Qube Research Technologies geht 0,53% Short in Lanxess ein
March 9, 2022 | msn.com
ANZ-Lanxess_Haie_KEC_Genesis
March 1, 2022 | msn.com
POINT72 Europe (London) kappt Short-Position in Lanxess
March 1, 2022 | msn.com
Standard Lithium-Aktie nach dem Lanxess-Deal: Das sind die Erfolgschancen!
February 15, 2022 | msn.com
POINT72 Europe (London) erhöht Short-Position in Lanxess
February 12, 2022 | msn.com
Köln: Lanxess Arena schießt gegen aktuelle Corona-Regeln
February 11, 2022 | msn.com
POINT72 Europe (London) geht 0,57% Short-Position in Lanxess ein
February 1, 2022 | msn.com
Lanxess-Arena-Chef unterstützt FC und BVB gegen Fan-Willkür
January 28, 2022 | msn.com
Zeitung - Lanxess und Advent an DSM-Sparte interessiert
January 26, 2022 | de.finance.yahoo.com
Clean Energy Transition erhöht Short-Position in Lanxess
January 19, 2022 | msn.com
Auftrtitt in der Lanxess Arena: Termin für Harry-Styles-Konzert in Köln steht fest
December 17, 2021 | markets.businessinsider.com
DGAP-PVR: LANXESS Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
December 9, 2021 | msn.com
3200 Spritzen am Tag möglich: Zu Fuß und per Rad zum Impfen in die Kölner Lanxess-Arena
December 7, 2021 | msn.com
Corona in Köln: Lanxess Arena eröffnet Schnelltest-Station
December 2, 2021 | msn.com
Wie viele Haie-Fans dürfen gegen Nürnberg in die Lanxess-Arena?
See More Headlines
Receive LNXSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LANXESS Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Chemicals - Major Diversified
Sub-Industry
N/A
Sector
Industrials
Current Symbol
OTCMKTS:LNXSF
CUSIP
N/A
CIK
N/A
Web
www.lanxess.com
Phone
(492) 218-8850
Fax
N/A
Employees
12,983
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$53.29
High Stock Price Forecast
$64.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+33.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Matthias Zachert
    Chairman-Management Board
  • Michael Pontzen
    Chief Financial Officer
  • Hubert Fink
    Member-Management Board
  • Anno Borkowsky
    Member-Management Board
  • Stephanie Cossmann
    Member-Management Board & Director-Labor Relations

Key Competitors

View All Competitors













LNXSF Stock - Frequently Asked Questions

Should I buy or sell LANXESS Aktiengesellschaft stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LANXESS Aktiengesellschaft in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LNXSF shares.
View LNXSF analyst ratings or view top-rated stocks.

What is LANXESS Aktiengesellschaft's stock price forecast for 2023?

7 Wall Street analysts have issued 1-year price objectives for LANXESS Aktiengesellschaft's stock. Their LNXSF share price forecasts range from $43.00 to $64.00. On average, they anticipate the company's share price to reach $53.29 in the next twelve months. This suggests a possible upside of 33.0% from the stock's current price.
View analysts price targets for LNXSF or view top-rated stocks among Wall Street analysts.

How have LNXSF shares performed in 2023?

LANXESS Aktiengesellschaft's stock was trading at $40.50 on January 1st, 2023. Since then, LNXSF shares have decreased by 1.1% and is now trading at $40.05.
View the best growth stocks for 2023 here.

Is LANXESS Aktiengesellschaft a good dividend stock?

LANXESS Aktiengesellschaft (OTCMKTS:LNXSF) pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.45%.

What is LANXESS Aktiengesellschaft's stock symbol?

LANXESS Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "LNXSF."

How do I buy shares of LANXESS Aktiengesellschaft?

Shares of LNXSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LANXESS Aktiengesellschaft's stock price today?

One share of LNXSF stock can currently be purchased for approximately $40.05.

How many employees does LANXESS Aktiengesellschaft have?

The company employs 12,983 workers across the globe.

How can I contact LANXESS Aktiengesellschaft?

LANXESS Aktiengesellschaft's mailing address is Kennedyplatz 1, Cologne, Nordrhein-Westfalen 50569. The official website for the company is www.lanxess.com. The company can be reached via phone at (492) 218-8850.

This page (OTCMKTS:LNXSF) was last updated on 3/25/2023 by MarketBeat.com Staff